BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11298597)

  • 21. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism.
    Kawase T; Matsuo K; Kashiwase K; Inoko H; Saji H; Ogawa S; Kato S; Sasazuki T; Kodera Y; Morishima Y;
    Blood; 2009 Mar; 113(12):2851-8. PubMed ID: 18997170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.
    Rutten CE; van Luxemburg-Heijs SA; Halkes CJ; van Bergen CA; Marijt EW; Oudshoorn M; Griffioen M; Falkenburg JH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):40-8. PubMed ID: 22871556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hla-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease.
    Gallardo D; Brunet S; Torres A; Alonso-Nieto M; Vallejo C; Jiménez A; González M; Sanz G; Serrano D; Espigado I; Osorio S; Carreras E; Martiín C; Sanz-Rodríguez C; Sierra J; Zuazu J; González-Escribano MF; González JR; Román J; De Oteyza JP; De La Cámara R
    Transplantation; 2004 Apr; 77(7):1107-10. PubMed ID: 15087781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation.
    van Balen P; van Luxemburg-Heijs SAP; van de Meent M; van Bergen CAM; Halkes CJM; Jedema I; Falkenburg JHF
    Transplantation; 2017 Dec; 101(12):2850-2854. PubMed ID: 28252558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
    Rutten CE; van Luxemburg-Heijs SA; Griffioen M; Marijt EW; Jedema I; Heemskerk MH; Posthuma EF; Willemze R; Falkenburg JH
    Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
    Madrigal A; Shaw BE
    Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
    Zou J; Kongtim P; Oran B; Kosmoliaptsis V; Carmazzi Y; Ma J; Li L; Rondon G; Srour S; Copley HC; Partlow D; Ciurea SO; Greenbaum U; Ma Q; Shpall EJ; Champlin RE; Cao K
    Haematologica; 2022 Apr; 107(4):844-856. PubMed ID: 34435482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe acute graft-versus-host disease by HLA-DPB1 disparity in recombinant family of bone marrow transplantation between serologically HLA-identical siblings: an application of the polymerase chain reaction-restriction fragment length polymorphism method.
    Nomura N; Ota M; Kato S; Inoko H; Tsuji K
    Hum Immunol; 1991 Dec; 32(4):261-8. PubMed ID: 1686026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
    Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.
    Mytilineos D; Tsamadou C; Neuchel C; Platzbecker U; Bunjes D; Schub N; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Mueller CR; Frank S; Schrezenmeier H; Fuerst D; Mytilineos J
    Front Immunol; 2020; 11():614976. PubMed ID: 33569061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs.
    Santamaria P; Reinsmoen NL; Lindstrom AL; Boyce-Jacino MT; Barbosa JJ; Faras AJ; McGlave PB; Rich SS
    Blood; 1994 Jan; 83(1):280-7. PubMed ID: 8274743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
    Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
    Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
    Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
    J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.
    Petersdorf EW; Carrington M; O'hUigin C; Bengtsson M; De Santis D; Dubois V; Gooley T; Horowitz M; Hsu K; Madrigal JA; Maiers MJ; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P;
    Lancet Haematol; 2020 Jan; 7(1):e50-e60. PubMed ID: 31669248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
    Ludajic K; Balavarca Y; Bickeböller H; Pohlreich D; Kouba M; Dobrovolna M; Vrana M; Rosenmayr A; Fischer GF; Fae I; Kalhs P; Greinix HT
    Br J Haematol; 2008 Jul; 142(3):436-43. PubMed ID: 18544086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.
    Thus KA; Ruizendaal MT; de Hoop TA; Borst E; van Deutekom HW; Te Boome L; Kuball J; Spierings E
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1705-10. PubMed ID: 24980111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
    Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
    N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.